Valuation: Stereotaxis, Inc.

Market Cap 10Cr 8.9Cr 8.25Cr 7.48Cr 14Cr 947.63Cr 14Cr 99Cr 39Cr 495.91Cr 38Cr 37Cr 1.58TCr P/E 2026 *
-4.91x
P/E 2027 * -6.81x
Enterprise Value 10Cr 8.9Cr 8.25Cr 7.48Cr 14Cr 947.63Cr 14Cr 99Cr 39Cr 495.91Cr 38Cr 37Cr 1.58TCr EV / Sales 2026 *
2.91x
EV / Sales 2027 * 2.19x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
1 day-1.16%
1 week-5.82%
Current month-18.84%
1 month-24.94%
3 months-33.45%
6 months-49.58%
Current year-56.60%
1 week 0.95
Extreme 0.95
1.07
1 month 0.95
Extreme 0.95
1.4
Current year 0.95
Extreme 0.95
2.86
1 year 0.95
Extreme 0.95
3.15
3 years 0.95
Extreme 0.95
3.59
5 years 0.95
Extreme 0.95
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/26 Free

Director

43,103 0.0441%
01/07/26 Free

Director

43,103 0.0441%
01/07/26
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-5.82%-67.80%-34.75% 10Cr
+1.18%+3.67%+26.39%+48.03% 25TCr
-0.08%+0.63%+7.61%+8.94% 16TCr
+1.11%+3.78%-4.46%+64.10% 15TCr
+1.18%+5.24%-54.66%-8.93% 6.61TCr
+0.59%+5.65%+11.46%+59.02% 5.16TCr
+1.00%+3.81%-14.33%-9.91% 5.18TCr
+1.23%+3.54%+17.27%+27.07% 5.09TCr
+1.83%+0.82%+20.99%+58.39% 4.88TCr
+1.97%+3.18%+29.04%+74.59% 4.35TCr
Average +0.08%+1.65%-2.85%+28.66% 8.79TCr
Weighted average by Cap. -0.37%+2.40%+7.52%+37.47%

Financials

2026 *2027 *
Net sales 3.43Cr 3.06Cr 2.83Cr 2.57Cr 4.82Cr 325.25Cr 4.9Cr 34Cr 13Cr 170.21Cr 13Cr 13Cr 542.99Cr 4.57Cr 4.06Cr 3.77Cr 3.41Cr 6.42Cr 432.61Cr 6.52Cr 45Cr 18Cr 226.39Cr 17Cr 17Cr 722.23Cr
Net income -2.01Cr -1.79Cr -1.66Cr -1.51Cr -2.83Cr -190.73Cr -2.88Cr -20Cr -7.83Cr -100Cr -7.55Cr -7.4Cr -318.41Cr -1.48Cr -1.31Cr -1.22Cr -1.1Cr -2.07Cr -139.89Cr -2.11Cr -15Cr -5.74Cr -73Cr -5.54Cr -5.42Cr -233.54Cr
Net Debt - -
Projected Income Statement - Annual - Stereotaxis, Inc.
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
20/26/20 $0.9983 -1.16% 6,37,378
19/26/19 $1.010 0.00% 8,89,682
16/26/16 $1.010 -3.81% 8,70,063
15/26/15 $1.050 0.00% 6,41,345
14/26/14 $1.050 -0.94% 6,92,256
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Stereotaxis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.9983USD
Average target price
3.000USD
Spread / Average Target
+200.51%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Stereotaxis, Inc.
  1. Stock Market
  2. Stocks
  3. STXS Stock